TerminatedPHASE2, PHASE3NCT00515281

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Chicago
Principal Investigator
Michael D. Schreiber, M.D.
University of Chicago
Intervention
inhaled nitric oxide(drug)
Enrollment
273 enrolled
Eligibility
All sexes
Timeline
20082023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00515281 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials